ELUT

Companies
NASDAQ
Elutia Inc.
Health Care
Price Chart
Overview

About ELUT

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Market Cap
$83.0M
Volume
48.4K
Avg. Volume
80.4K
P/E Ratio
-2.3636363
Dividend Yield
0.00%
Employees
108.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Medical Devices
Risk & Correlation Analysis
Market Correlation
0.26
Low Correlation
Volatility
High (0.98)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ELUT.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ELUT shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$83.0M
Volume48.4K
P/E Ratio-2.36
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 7, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how ELUT fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025